Open AccessClinical features of hemophagocytic syndrome following BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma
Author(s) -
Cheng Zu,
Kexin Wang,
Qiqi Zhang,
Yongxian Hu,
He Huang
Publication year - 2022
Publication title -
zhejiang daxue xuebao. yixue ban
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.14
H-Index - 13
ISSN - 1008-9292
DOI - 10.3724/zdxbyxb-2022-0039
Subject(s) - medicine , cytokine release syndrome , multiple myeloma , gastroenterology , refractory (planetary science) , chimeric antigen receptor , tocilizumab , t cell , immunology , immunotherapy , immune system , cancer , physics , disease , astrobiology
To analyze the clinical features of hemophagocytic syndrome (HLH) following B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T cell therapy in patients with relapsed/refractory multiple myeloma.